Home › Trials › NCT05002556

Registry for managing and following up on non-muscle-invasive bladder cancer

AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer

Observational Association Francaise d'Urologie · NCT05002556

This study is trying to see how well current treatments and urine tests work for people with non-muscle-invasive bladder cancer to help doctors manage their care better.

Quick facts

Study typeObservational
Enrollment8000 (estimated)
Ages18 Years and up
SexAll
SponsorAssociation Francaise d'Urologie Academic / other
Locations44 sites (Aix-en-Provence and 43 other locations)
Trial IDNCT05002556 on ClinicalTrials.gov

What this trial studies

The AFU has established a registry to improve the therapeutic management and follow-up of patients with non-muscle-invasive bladder cancer (NMIBC). This observational study aims to collect representative data from urologists who are members of the AFU, focusing on patients monitored for NMIBC. The study will analyze the effectiveness of current management practices and the role of urinary molecular tests in monitoring these patients. Regular endoscopic examinations and urine cytology are emphasized for detecting tumor recurrence.

Who should consider this trial

Good fit: Ideal candidates include adults over 18 years old who are being monitored for non-muscle-invasive bladder tumors and have undergone a urinary molecular test prior to their diagnosis or recurrence.

Not a fit: Patients with non-urothelial bladder tumors or those who refuse follow-up will not benefit from this study.

Why it matters

Potential benefit: If successful, this registry could lead to enhanced management strategies and improved outcomes for patients with non-muscle-invasive bladder cancer.

How similar studies have performed: While this approach is observational and builds on existing practices, similar registries have shown success in improving patient outcomes in other cancer types.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Patient being monitored for a non-muscle-invasive bladder tumor and having undergone a urinary test (biomarker) prior to their resection (biopsy) diagnosis or recurrence,
* AND adult (equal to or \> 18 years old),
* AND affiliated with a social security scheme in France,
* AND whose monitoring will be carried out at the recruiting center.

Exclusion Criteria:

* Patient being monitored for a non-urothelial bladder tumor
* Patient refusing follow-up
* Opposition to participation in the study
* Adult protected by law

Where this trial is running

Aix-en-Provence and 43 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Non-Muscle-Invasive Bladder CancerBladder cancer, urine test, recurrence
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.